首頁
Neon Therapeutics

7月 2026Neon Therapeutics的市場佔有率分析

at biontech we believe that every cancer patient’s treatment should be individualized. our vision is to provide patient-specific immunotherapies worldwide.

健康 > 生物技術和製藥

域名neontherapeutics.com

成立年份2015

僱員51 - 200

年度營收$1M - $2M

Neon Therapeutics

Neon Therapeutics（包含公司地區）

neontherapeutics.com

查看更多網站流量與參與度資訊

Neon Therapeutics截至 7月 2026 的總收入為 1M - 2M

Neon Therapeutics 熱門網域產生的總收入

Neon Therapeutics 熱門網域 3 年內的總收入

Neon Therapeutics 熱門網域的總收入

neontherapeutics.com1M - 2M

透過銷售情報查看更多內容

Neon Therapeutics的熱門網域總造訪量

了解Neon Therapeutics市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

無可顯示數據

Neon Therapeutics的熱門網域平均造訪時長

分析Neon Therapeutics參與度指標。

過去 3 個月平均造訪時長

無可顯示數據

Neon Therapeutics的熱門網域平均頁面瀏覽量

了解Neon Therapeutics如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

無可顯示數據

Neon Therapeutics按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術Neon Therapeutics

这些是Neon Therapeutics顶级域名使用的行业网站技术

小工具 (5)

Twemoji

內容管理系統 (3)

WordPress

音訊視訊媒體 (2)

YouTube

付費廣告 (1)

DoubleClick

更多技術

7

檢視所有

新聞與訊號來自Neon Therapeutics

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Neon Therapeutics Inc sold assets to BioNTech US Inc. in the amount of $70M on Jan 1st '20.Inbio Ventures contributed to the $70m Series B funding raised for the development of drugs BioNTech acquired from Neon Therapeutics through its acquisition of the company in January 2020.

新聞Ang left Neon Therapeutics Inc as Chief Business Officer on Jan 1st '19.Dr. Ang joined Vor Biopharma in 2019 from Neon Therapeutics (acquired by BioNTech) where, as Chief Business Officer, he helped oversee the company's transformation from pre-seed stage through to a successful NASDAQ IPO.

新聞Neon Therapeutics Inc has issues with violations of the Securities Exchange Act of 1934.The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Neon, its Board of Directors (the “Board”), BioNTech, and Merger Sub, is captioned Franchi v. Neon Therapeutics, Inc., Case No. 1:20-cv-00482 (D. Del.).